Guidance Needed To Explain Scope Of MDR’s Confusing Clinical Investigations Clause
Executive Summary
Article 61(5) of the EU’s Medical Device Regulation gives certain manufacturers an exemption from having to perform clinical investigations by demonstrating equivalence to other companies’ products. But to whom does it apply and who could actually make use of it? Dr. Maria Donawa explains why clarification is urgently needed.
You may also be interested in...
Importer And Distributor Repackaging And Relabeling In The EU: New Guidance Published
It is vital that importers and distributors in the EU who are repackaging and relabeling medical devices know their responsibilities under the new MDR and are aware that they could be moving into manufacturer territory. New guidance spells out the new rules.
Delving Deeper Into How EU Rules For Legacy Devices Apply
Guidance has been issued on exactly how the Medical Device Regulation requirements apply to ‘legacy’ and ‘old’ devices which remain on the market in compliance with the medical device directives.
EU Has Now Designated 30 Notified Bodies For Medtech Products
Latest EU MDR notified body designation brings total in Italy to six, the same as Germany.